Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.725
Bid: 1.60
Ask: 1.85
Change: 0.00 (0.00%)
Spread: 0.25 (15.625%)
Open: 1.725
High: 1.725
Low: 1.725
Prev. Close: 1.725
LSAA Live PriceLast checked at -
Life Settlement Assets A is an Investment Trust

To generate long-term returns for investors by investing in the life settlement market.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to the Specialist Fund Segment

26 Mar 2018 08:05

RNS Number : 8278I
Life Settlement Assets PLC
26 March 2018
 

 

Life Settlement Assets PLC

LEI: 2138003OL2VBXWG1BZ27

(the "Company" or "LSA") 

Admission to the Specialist Fund Segment

 

 

The directors of LSA are pleased to announce that the Company's entire issued share capital comprising 45,446,946 A Ordinary Shares of $0.01 each, 14,596,098 B Ordinary Shares of $0.01 each, 9,292,561 D Ordinary Shares of $0.01 each and 1,733,269 E Ordinary Shares of $0.01 each has been admitted to the Specialist Fund Segment of the London Stock Exchange ("Admission") at 8.00 a.m. today. Each Share carries the same voting rights (save in respect of matters relating solely to a specific Share Class), therefore the total number of voting rights in the Company is 71,068,874. Trading in the Predecessor Company's shares on the Luxembourg Stock Exchange was cancelled on 6 March 2018.

 

Shareholders should note that the obligations for shareholders to notify the Company of their shareholding apply at a lower threshold than was the case in Luxembourg. Under Chapter 5 of the Disclosure Guidance and Transparency Rules (the "DTRs"), subject to certain limited expectations, a person must notify the Company (and, at the same time, the FCA) of the percentage of voting rights he holds (within two trading days) if he acquires or disposes of Shares in the Company to which voting rights are attached and if, as a result of the acquisition or disposal, the percentage of voting rights which he holds as a Shareholder (or, in certain cases, which he holds indirectly) or through his direct or indirect holding of certain types of financial instruments (or a combination of such holdings):

 

(a) reaches, exceeds or falls below 3, 4, 5, 6, 7, 8, 9 or 10 per cent. and each 1 per cent threshold thereafter up to 100 per cent; or

(b) reaches, exceeds or falls below an applicable threshold in (a) above as a result of events changing the breakdown of voting rights and on the basis of the total voting rights notified to the market by the Company.

 

Such notification must be made using the prescribed form TR1 available from the FCA's website at http://www.fca.gov.uk. Under the DTRs, the Company must announce the notification to the public as soon as possible and in any event by not later than the end of the trading day following receipt of a notification in relation to voting rights."

 

The Company is a newly established closed-ended investment company whose principal activities are to support and manage portfolios of whole and partial interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company's investment objective is to generate long-term returns for investors by investing in the life settlement market.

 

Acheron Capital Limited ("Acheron") is responsible for devising and modelling the investment strategy of the Company's trusts. Founded in 2006 by Dr. Jean-Michel Paul, Acheron is a London based independent investment manager authorised and regulated by the Financial Conduct Authority that focuses on niche investment strategies uncorrelated to the traditional financial markets.

 

The Company believes that its admission to the Specialist Fund Segment provides it with the ideal platform to enhance the reputation, marketability, liquidity, and valuation of the Company's shares by gaining access to a wider investor audience.

 

The prospectus published by the Company on 30 January 2018 and the supplementary prospectus published by the Company on 23 March 2018 in connection with the Admission can be found on the Company's website www.lsaplc.com, and at the National Storage Mechanism at http://www.morningstar.co.uk/uk/NSM.

 

Save for expressions defined in this announcement, words and expressions defined in the Prospectus shall have the same meaning in this announcement.

 

For further information contact

 

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Stockdale Securities Limited (Financial Adviser and Broker)

Robert Finlay / Owen Matthews

020 7601 6115

 

TB Cardew (Financial PR)

Shan Shan Willenbrock

020 7930 0777

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDXLFLVXFBBBB
Date   Source Headline
20th Jun 20192:56 pmRNSShare Premium Account & Dividend Declaration
13th Jun 20195:31 pmRNSResult of AGM
6th Jun 20197:00 amRNSNet Asset Value(s)
4th Jun 201911:53 amRNSTender Offer
30th May 20197:00 amRNSChange of Adviser
15th May 20195:26 pmRNSReport and Accounts and AGM Notice of Meetings
14th May 20197:00 amRNSReturn of Capital
13th May 20197:00 amRNSNet Asset Value(s)
30th Apr 20195:15 pmRNSAnnual Financial Report
8th Apr 20197:00 amRNSNet Asset Value(s)
18th Mar 20199:36 amRNSNet Asset Value(s)
6th Mar 20197:00 amRNSMaturity Notice
13th Feb 20198:42 amRNSNet Asset Value(s) - Replacement
13th Feb 20197:00 amRNSNet Asset Value(s)
14th Jan 20197:00 amRNSNet Asset Value(s)
7th Jan 20193:03 pmRNSPolicy Maturities
14th Dec 20183:15 pmRNSNet Asset Value(s)
9th Nov 20187:00 amRNSNet Asset Value(s)
15th Oct 20182:17 pmRNSFinancial Results for Period ended 30 June 2018
12th Oct 20187:00 amRNSNet Asset Value(s)
1st Oct 20184:36 pmRNSStatement re (Submission of Document)
28th Sep 20184:10 pmRNSFinancial Results for Period ended 30 June 2018
25th Sep 20184:13 pmRNSChange of Registered Office
14th Sep 20187:00 amRNSNet Asset Value(s)
13th Aug 20187:00 amRNSNet Asset Value(s)
12th Jul 20187:00 amRNSNet Asset Value(s)
9th Jul 20187:00 amRNSStatement re Share Dealing
29th Jun 20182:25 pmRNSStatement re Share Dealings
19th Jun 201812:00 pmRNSStatement re Company Presentation
15th Jun 20187:00 amRNSNet Asset Value(s)
31st May 20189:19 amRNSNet Asset Value(s)
21st May 20189:45 amRNSHolding(s) in Company
10th May 20187:00 amRNSStatement re Policy Maturities
20th Apr 201810:42 amRNSHolding(s) in Company
3rd Apr 20181:56 pmRNSTotal Voting Rights
3rd Apr 201811:42 amRNSHolding(s) in Company
26th Mar 20188:05 amRNSAdmission to the Specialist Fund Segment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.